Risk factor
Poor trading liquidity
Profitability factor
Undervalued vs peers
About
Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients (APIs) worldwide. The company offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, and antibiotics. It also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates;...
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on EV/EBITDA
Target Price
The average target price of 4746.TW is 106 and suggests 87% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell